We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly is airing an ad during the Academy Awards urging customers to adopt a health skepticism when marketed drug brands that are not FDA-approved.
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
Eli Lilly is partnering with Imagine Entertainment and MACRO to drive industry-wide change and guide in authentically ...
2d
Verywell Health on MSNEli Lilly Lowers Cost of Zepbound Vials to Attract People Without Insurance CoverageEli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...
13hon MSN
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results